respiratory therapy
Phase 1 study supports further development of inhaled respiratory therapy
June 25, 2026Research and Development Kither Biotech, respiratory therapy
Kither Biotech has reported positive results from a phase 1 study of KIT2014, an investigational inhaled therapy being developed for …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
AI: an early warning system for patient safety
November 3, 2026
